β-Blocker Use in Pregnancy and the Risk for Congenital Malformations

Affiliations

¹ Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (B.T.B., K.F.H.).
² Harvard T.H. Chan School of Public Health, Boston, Massachusetts (S.H.).
³ Karolinska Institutet, Stockholm, Sweden (H.K.).
⁴ University of New South Wales, Sydney, New South Wales, Australia (H.Z.).

Comment

Brian T Bateman et al. Ann Intern Med. 2019.

. 2019 Jun 18;170(12):909-910.

doi: 10.7326/L19-0157.

¹ Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (B.T.B., K.F.H.).
² Harvard T.H. Chan School of Public Health, Boston, Massachusetts (S.H.).
³ Karolinska Institutet, Stockholm, Sweden (H.K.).
⁴ University of New South Wales, Sydney, New South Wales, Australia (H.Z.).

No abstract available

Comment on

β-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study.
Bateman BT, Heide-Jørgensen U, Einarsdóttir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Selmer R, Huybrechts KF, Zoega H. Bateman BT, et al. Ann Intern Med. 2018 Nov 20;169(10):665-673. doi: 10.7326/M18-0338. Epub 2018 Oct 16. Ann Intern Med. 2018. PMID: 30326014 Free PMC article.
β-Blocker Use in Pregnancy and the Risk for Congenital Malformations.
Shantsila A, Beevers DG, Lip GYH. Shantsila A, et al. Ann Intern Med. 2019 Jun 18;170(12):909. doi: 10.7326/L19-0156. Ann Intern Med. 2019. PMID: 31207629 No abstract available.